AVATAR: Efficacy of personalized tumorogram-based therapy in breast cancer established from patient-derived organoids.
Luc Cabel(Université de Versailles Saint-Quentin-en-Yvelines), Elisabetta Marangoni(Institut Curie), Matthieu Carton(Institut Curie), Régis Audoual, Romane Florent(Inserm), Louis‐Bastien Weiswald(Inserm), Alexandre De Moura(Institut Curie), Juliette Sauge(Inserm), Antoine Vasseur, Paul Cottu(Université Paris Cité), Anne Vincent-Salomon(Institut Curie), Thomas Gaillard, Rania El Botty, Delphine Loirat(Institut Curie), Laurent Poulain(Université de Caen Normandie), Toulsie Ramtohul(Université Paris Sciences et Lettres), Laura Sourd, D. Cochereau
Cited by 0
Related Papers
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
|Critical Reviews in Oncology/Hematology|2018|268
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area
|Breast Cancer Research|2020|125
Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers
|Radiology|2023|122
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers
|Nature Communications|2023|96
Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients
|JNCI Cancer Spectrum|2020|60